These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 3494659

  • 1. Efforts to produce human cytotoxic T-cell hybridomas by electrofusion and PEG fusion.
    Gravekamp C, Santoli D, Vreugdenhil R, Collard JG, Bolhuis RL.
    Hybridoma; 1987 Apr; 6(2):121-33. PubMed ID: 3494659
    [Abstract] [Full Text] [Related]

  • 2. Direct comparison of electric field-mediated and PEG-mediated cell fusion for the generation of antibody producing hybridomas.
    Karsten U, Stolley P, Walther I, Papsdorf G, Weber S, Conrad K, Pasternak L, Kopp J.
    Hybridoma; 1988 Dec; 7(6):627-33. PubMed ID: 3235098
    [Abstract] [Full Text] [Related]

  • 3. Efficient electric field-induced generation of hybridomas from human B lymphocytes without prior activation in vitro.
    Kwekkeboom J, de Groot C, Tager JM.
    Hum Antibodies Hybridomas; 1992 Jan; 3(1):48-53. PubMed ID: 1576322
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Preferential generation of human T cell hybrids with a tetraploid fusion partner.
    Berger AE, Kuentzel SL, Davidson SO.
    J Immunol; 1985 Sep; 135(3):1792-9. PubMed ID: 3874906
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cell activation by CpG ODN leads to improved electrofusion in hybridoma production.
    Kato M, Sasamori E, Chiba T, Hanyu Y.
    J Immunol Methods; 2011 Oct 28; 373(1-2):102-10. PubMed ID: 21878337
    [Abstract] [Full Text] [Related]

  • 11. Evidence for quantitative and qualitative differences in functional activation of Mls-reactive T cell clones and hybridomas by antigen or TcR/CD3 antibodies.
    Gaugler B, Langlet C, Martin JM, Schmitt-Verhulst AM, Guimezanes A.
    Eur J Immunol; 1991 Oct 28; 21(10):2581-9. PubMed ID: 1680703
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Attempts to improve hybridoma technology for the production of human monoclonal antibodies].
    Tokunaga T, Chiba J, Ohnishi K.
    Gan To Kagaku Ryoho; 1987 Jun 28; 14(6 Pt 2):2198-204. PubMed ID: 3038035
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Construction of human-mouse T cell hybrids that express human T cell-associated surface antigens and allow the chromosomal localization of these antigens.
    van Dongen JJ, Geurts van Kessel AH, Wolvers-Tettero IL, Versnel MA, van Oudenaren A, Schoenmaker E, Hagemeijer A.
    J Immunol; 1986 Aug 01; 137(3):1047-53. PubMed ID: 3487584
    [Abstract] [Full Text] [Related]

  • 18. Comparison of three human-murine heteromyeloma cell lines for formation of human hybridomas after electrofusion with human peripheral blood lymphocytes from meningococcal cases and carriers.
    Delvig AA, Koumaré B, Glaser RW, Wang JF, Jahn S, Achtman M.
    Hum Antibodies Hybridomas; 1995 Aug 01; 6(2):42-6. PubMed ID: 7492749
    [Abstract] [Full Text] [Related]

  • 19. [Hybridomas synthesizing monoclonal antibodies to surface antigens of human lymphocytes].
    Seregina TM, Mekshenkov MI.
    Tsitologiia; 1986 Sep 01; 28(9):976-80. PubMed ID: 3798564
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.